Ozempic vs Wegovy: Same Medication, Different Purpose

Both contain semaglutide — but one is approved for diabetes and the other for weight management. Here's what that means for you.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · Ozempic vs Wegovy is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated March 2026Medically reviewed by licensed providers

Ozempic vs Wegovy: both are FDA-approved GLP-1 medications for weight loss. Ozempic (semaglutide) and Wegovy (semaglutide) differ in mechanism and clinical efficacy. Weight Method offers both from $297/month with virtual consultations and licensed providers.

Overview

Ozempic and Wegovy are both once-weekly injectable pens made by Novo Nordisk containing semaglutide, a GLP-1 receptor agonist. The critical distinction is their FDA-approved indications: Ozempic (approved 2017) is indicated for type 2 diabetes management, while Wegovy (approved 2021) is specifically approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity. Wegovy reaches a higher maximum dose of 2.4 mg compared to Ozempic's 2 mg ceiling, which contributes to its stronger weight loss outcomes.

Key Fact

Ozempic and Wegovy contain the same active ingredient (semaglutide) but differ in approved indication and maximum dose. Ozempic: FDA-approved for type 2 diabetes, max 2mg. Wegovy: FDA-approved for weight management, max 2.4mg. STEP 1 showed 14.9% average weight loss with Wegovy dosing.

Source: FDA prescribing information; STEP 1 Trial, NEJM 2021

Ozempic

ManufacturerNovo Nordisk
Active Ingredientsemaglutide
FDA IndicationType 2 diabetes
FDA Approval2017
FormulationInjectable pen
FrequencyOnce weekly
Available Doses0.25mg, 0.5mg, 1mg, 2mg
Avg. Weight Loss10-15%
Our Price$297/mo

Wegovy

ManufacturerNovo Nordisk
Active Ingredientsemaglutide
FDA IndicationChronic weight management
FDA Approval2021
FormulationInjectable pen
FrequencyOnce weekly
Available Doses0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg
Avg. Weight Loss15-17%
Our Price$297/mo

Key Differences

The primary difference is indication and dosing ceiling. Ozempic tops out at 2 mg and delivers 10-15% average body weight loss, while Wegovy escalates to 2.4 mg with clinical trials showing 15-17% average weight loss. Insurance coverage varies significantly — many plans cover Ozempic for diabetes but not Wegovy for weight loss, which has driven widespread off-label Ozempic prescribing. Both medications cost $297/mo through Weight Method's subscription program.

Verdict

If you have type 2 diabetes and want weight loss as a secondary benefit, Ozempic is the straightforward choice with strong insurance support. If your primary goal is weight management without a diabetes diagnosis, Wegovy is the purpose-built option with a higher dose ceiling and stronger weight loss data. Through Weight Method, both are available at $297/mo with a licensed provider consultation.

Ready to Get Started?

Answer a few quick questions to see if you qualify for GLP-1 medication.

Check Eligibility

Your Treatment Options

Clinically proven GLP-1 medications at transparent prices

Starting at$297/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Same active ingredient as Ozempic® & Wegovy®. Proven to reduce body weight by up to 15%.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Same active ingredient as Mounjaro® & Zepbound®. Dual-action GLP-1/GIP for enhanced results.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

They contain the same active ingredient — semaglutide — made by the same manufacturer (Novo Nordisk), but they are different FDA-approved medications. Ozempic is approved for type 2 diabetes at doses up to 2 mg, while Wegovy is approved for chronic weight management at doses up to 2.4 mg.

Wegovy generally produces more weight loss due to its higher maximum dose (2.4 mg vs 2 mg). Clinical trials show Wegovy patients losing 15-17% of body weight on average, compared to 10-15% with Ozempic. However, individual results vary based on diet, exercise, and starting weight.

Ozempic is frequently prescribed off-label for weight loss, though it is only FDA-approved for type 2 diabetes. Many patients and doctors choose Ozempic because insurance coverage is more widely available. Your provider can help determine which medication and indication is appropriate for your situation.

Yes, the side effect profiles are nearly identical since both contain semaglutide. The most common side effects include nausea, vomiting, diarrhea, constipation, and abdominal pain. Side effects are typically most noticeable during dose escalation and tend to improve over time.

Retail prices for both medications exceed $1,000/month without insurance. Through Weight Method's subscription program, compounded semaglutide is available at $297/month with an online provider consultation, medical review, and ongoing support included.

Ready to Get Started?

Take our 2-minute quiz to see if you qualify for GLP-1 treatment.

Start Quiz

Free consultation. No commitment.

Related Brand Pages

Ozempic HubOzempic Side EffectsOzempic ResultsOzempic DosingWegovy HubWegovy Side EffectsWegovy ResultsWegovy Dosing

More Comparisons

Mounjaro vs ZepboundRybelsus vs Oral-wegovyOzempic vs MounjaroWegovy vs ZepboundOzempic vs ZepboundWegovy vs Mounjaro